All In MedTech

Device Trial Radar · NCT07880288

YO® Smartphone Home Sperm Test Versus Manual Semen Analysis in Egyptian Men

Comparative Evaluation of the Smart Phone-Based Self-Used Sperm Testing Device Versus Manual Semen Analysis in an Andrology Laboratory Setting

Last checked: Nov 19, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

20

Actual

Start

Mar 10, 2026

Primary completion

Sep 28, 2026

Study completion Nov 30, 2026

Sponsor

Lead sponsor
Armed Forces College of Medicine, Cairo, EgyptAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Al-Azhar University; International Islamic Center for Population Studies and Research
First posted
Oct 19, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
No
Who can join
Male only, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study compares the YO® Home Sperm Test, a smartphone-based semen testing device, with conventional manual semen analysis performed according to the World Health Organization (WHO) 6th edition laboratory manual. Each participant provides one semen sample. A small aliquot is taken for testing with the YO® device, performed by the participant himself under supervision according to the manufacturer's instructions, and the remainder of the sample is analyzed manually in the andrology laboratory. The main question is how closely the motile sperm concentration (MSC) measured by the YO® device correlates with the MSC calculated from manual analysis. Secondary comparisons include sperm concentration, total motility, progressive motility and progressively motile sperm concentration. The study also compares the time needed to obtain results by each method and assesses participants' ease of use and satisfaction with the device. The aim is to determine whether this device could serve as a private, accessible screening tool for male fertility in Egypt.

Conditions

  • Semen Analysis
  • Male Infertility

Interventions

  • YO® Home Sperm TestDevice

    FDA-cleared smartphone-based semen testing device that uses a miniature optical attachment and the smartphone camera to record a video of the semen sample and report sperm concentration, total motility, progressive motility, motile sperm concentration (MSC) and progressively motile sperm concentration. Performed by the participant after demonstration, under supervision of trained medical personnel.

  • Manual Semen Analysis (WHO 6th Edition)Diagnostic test

    Conventional microscopic semen analysis performed by trained laboratory personnel according to the WHO Laboratory Manual for the Examination and Processing of Human Semen (6th edition, 2021), including sperm concentration, total motility and progressive motility, with manual calculation of MSC and progressively motile sperm concentration.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Correlation Between YO® and Manual Motile Sperm Concentration (MSC)Time frame: Day 1 (single study visit, within 1 hour of semen sample collection)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Andrology Laboratory, Faculty of Medicine, Al-Azhar University

    Cairo, Cairo Governorate, Egypt

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.